{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:33:16Z","timestamp":1790785996096,"version":"4.1.0"},"reference-count":63,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2016,10,10]]},"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Although several pharmacological agents have emerged as potential adjunctive therapies to a gluten-free diet for coeliac disease, there is currently no widely accepted measure of disease activity used in clinical trials. We conducted a systematic review of coeliac disease activity indices to evaluate their operating properties and potential as outcome measures in registration trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>MEDLINE, EMBASE and the Cochrane central library were searched from 1966 to 2015 for eligible studies in adult and\/or paediatric patients with coeliac disease that included coeliac disease activity markers in their outcome measures. The operating characteristics of histological indices, patient-reported outcomes (PROs) and endoscopic indices were evaluated for content and construct validity, reliability, responsiveness and feasibility using guidelines proposed by the US Food and Drug Administration (FDA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 19\u2005123 citations, 286 studies were eligible, including 24 randomised-controlled trials. Three of five PROs identified met most key evaluative criteria but only the Celiac Disease Symptom Diary (CDSD) and the Celiac Disease Patient-Reported Outcome (CeD PRO) have been approved by the FDA. All histological and endoscopic scores identified lacked content validity. Quantitative morphometric histological analysis had better reliability and responsiveness compared with qualitative scales. Endoscopic indices were infrequently used, and only one index demonstrated responsiveness to effective therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Current best evidence suggests that the CDSD and the CeD PRO are appropriate for use in the definition of primary end points in coeliac disease registration trials. Morphometric histology should be included as a key secondary or co-primary end point. Further work is needed to optimise end point configuration to inform efficient drug development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2016-312762","type":"journal-article","created":{"date-parts":[[2016,10,31]],"date-time":"2016-10-31T21:49:15Z","timestamp":1477950555000},"page":"61-69","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":48,"title":["Disease activity indices in coeliac disease: systematic review and recommendations for clinical trials"],"prefix":"10.1136","volume":"67","author":[{"given":"Pieter","family":"Hindryckx","sequence":"first","affiliation":[{"name":"Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada"},{"name":"Department of Gastroenterology, University of Ghent, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrett G","family":"Levesque","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada"},{"name":"Division of Gastroenterology, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4540-4012","authenticated-orcid":false,"given":"Tom","family":"Holvoet","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Ghent, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serina","family":"Durand","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3850-4442","authenticated-orcid":false,"given":"Ceen-Ming","family":"Tang","sequence":"additional","affiliation":[{"name":"Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, Oxford, UK"},{"name":"Oxford University Clinical Academic Graduate School, John Radcliffe Hospital, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Parker","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reena","family":"Khanna","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada"},{"name":"Department of Medicine, University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M","family":"Shackelton","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"D'Haens","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada"},{"name":"In\ufb02ammatory Bowel Disease Centre, Academic Medical Centre, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J","family":"Sandborn","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada"},{"name":"Division of Gastroenterology, University of California San Diego, La Jolla, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian G","family":"Feagan","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada"},{"name":"Department of Medicine, University of Western Ontario, London, Ontario, Canada"},{"name":"Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lebwohl","sequence":"additional","affiliation":[{"name":"Celiac Disease Center, Columbia University, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A","family":"Leffler","sequence":"additional","affiliation":[{"name":"The Celiac Center, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipul","family":"Jairath","sequence":"additional","affiliation":[{"name":"Robarts Clinical Trials Inc., University of Western Ontario, London, Ontario, Canada"},{"name":"Department of Medicine, University of Western Ontario, London, Ontario, Canada"},{"name":"Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2016,10,31]]},"reference":[{"key":"2025120520070139000_67.1.61.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4347"},{"key":"2025120520070139000_67.1.61.2","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2010.23"},{"key":"2025120520070139000_67.1.61.3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2005.02.010"},{"key":"2025120520070139000_67.1.61.4","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.194"},{"key":"2025120520070139000_67.1.61.5","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2015.156"},{"key":"2025120520070139000_67.1.61.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2015.09.002"},{"key":"2025120520070139000_67.1.61.7","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.105"},{"key":"2025120520070139000_67.1.61.8","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/gov006"},{"key":"2025120520070139000_67.1.61.9","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.29"},{"key":"2025120520070139000_67.1.61.10","doi-asserted-by":"publisher","DOI":"10.1159\/000441697"},{"key":"2025120520070139000_67.1.61.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.07.025"},{"key":"2025120520070139000_67.1.61.12","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31821a23d0"},{"key":"2025120520070139000_67.1.61.13","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(85)90005-0"},{"key":"2025120520070139000_67.1.61.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2006.03.012"},{"key":"2025120520070139000_67.1.61.15","unstructured":"United States Food and Drug Administration. Guidance for industry patient-reported outcome measures: use in medical product development to support labeling claims. US Department of Health and Human Services, 2009."},{"key":"2025120520070139000_67.1.61.16","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91819-P"},{"key":"2025120520070139000_67.1.61.17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease: time for a standardized report scheme for pathologists","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025120520070139000_67.1.61.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0300-2977(98)00050-3"},{"key":"2025120520070139000_67.1.61.19","first-page":"371","article-title":"Comparison of the Marsh-Oberhuber classification with a new grading system in identifying patients with latent celiac disease","volume":"56","author":"Villanacci","year":"2010","journal-title":"Minerva Gastroenterol Dietol"},{"key":"2025120520070139000_67.1.61.20","doi-asserted-by":"crossref","first-page":"826","DOI":"10.5858\/134.6.826","article-title":"Gluten-sensitive enteropathy (celiac disease): controversies in diagnosis and classification","volume":"134","author":"Ensari","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"2025120520070139000_67.1.61.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076163"},{"key":"2025120520070139000_67.1.61.22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.03992.x"},{"key":"2025120520070139000_67.1.61.23","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12621"},{"key":"2025120520070139000_67.1.61.24","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/905325"},{"key":"2025120520070139000_67.1.61.25","doi-asserted-by":"publisher","DOI":"10.1007\/BF01535722"},{"key":"2025120520070139000_67.1.61.26","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2012.211"},{"key":"2025120520070139000_67.1.61.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.09.030"},{"key":"2025120520070139000_67.1.61.28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.02.008"},{"key":"2025120520070139000_67.1.61.29","doi-asserted-by":"crossref","first-page":"S603","DOI":"10.14309\/00000434-201210001-01509","article-title":"Celiac disease symptom frequency and severity using a disease-specific patient-reported outcome diary: Observations from a psychometric validation study in 202 patients","volume":"107","author":"Adelman","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"2025120520070139000_67.1.61.30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04220.x"},{"key":"2025120520070139000_67.1.61.31","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000225516.05666.4e"},{"key":"2025120520070139000_67.1.61.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.07.031"},{"key":"2025120520070139000_67.1.61.33","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2000.104977"},{"key":"2025120520070139000_67.1.61.34","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2003.54"},{"key":"2025120520070139000_67.1.61.35","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-925178"},{"key":"2025120520070139000_67.1.61.36","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-945044"},{"key":"2025120520070139000_67.1.61.37","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-008-0486-5"},{"key":"2025120520070139000_67.1.61.38","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.01.010"},{"key":"2025120520070139000_67.1.61.39","unstructured":"United States of America Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/K032571.pdf (accessed 16 Jun 2016)."},{"key":"2025120520070139000_67.1.61.40","unstructured":"United States of America Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/k060157.pdf (accessed 16 Jun 2016)."},{"key":"2025120520070139000_67.1.61.41","unstructured":"United States of America Food and Drug Administration. http:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/K113863.pdf (accessed 16 Jun 2016)."},{"key":"2025120520070139000_67.1.61.42","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302196"},{"key":"2025120520070139000_67.1.61.43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0017366"},{"key":"2025120520070139000_67.1.61.44","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12232"},{"key":"2025120520070139000_67.1.61.45","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2011.627447"},{"key":"2025120520070139000_67.1.61.46","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MCG.0b013e3181cadbc0","article-title":"Fecal calprotectin concentration in celiac disease","volume":"44","author":"Ertekin","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"2025120520070139000_67.1.61.47","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i2.611"},{"key":"2025120520070139000_67.1.61.48","unstructured":"United States Food and Drug Administration. http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm363474.htm (accessed 16 Jun 2016)."},{"key":"2025120520070139000_67.1.61.49","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-13-40"},{"key":"2025120520070139000_67.1.61.50","first-page":"131","article-title":"Comparison of drug approval process in United States & Europe","volume":"5","author":"Kashyap","year":"2013","journal-title":"J Pharm Sci Res"},{"key":"2025120520070139000_67.1.61.51","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13703"},{"key":"2025120520070139000_67.1.61.52","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3923"},{"key":"2025120520070139000_67.1.61.53","first-page":"1402","article-title":"Therapy options in irritable bowel syndrome","volume":"22","author":"Enck","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2025120520070139000_67.1.61.54","doi-asserted-by":"crossref","first-page":"8796","DOI":"10.3748\/wjg.v20.i27.8796","article-title":"Irritable bowel syndrome: a concise review of current treatment concepts","volume":"20","author":"Wall","year":"2014","journal-title":"World J Gastroenterol"},{"key":"2025120520070139000_67.1.61.55","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-159-3-201308060-00006"},{"key":"2025120520070139000_67.1.61.56","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3164"},{"key":"2025120520070139000_67.1.61.57","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.04.007"},{"key":"2025120520070139000_67.1.61.58","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv074"},{"key":"2025120520070139000_67.1.61.59","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00068-9"},{"key":"2025120520070139000_67.1.61.60","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-309598"},{"key":"2025120520070139000_67.1.61.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.02.016"},{"key":"2025120520070139000_67.1.61.62","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62113-9"},{"key":"2025120520070139000_67.1.61.63","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61000-4"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2016-312762","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:07:08Z","timestamp":1764994028000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2016-312762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,31]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12,12]]},"published-print":{"date-parts":[[2018,1]]}},"alternative-id":["10.1136\/gutjnl-2016-312762"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2016-312762","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,31]]}}}